Dickkopf1 as a Potential Biomarker in Polycystic Ovary Syndrome and Insulin Resistance: A Cross‐Sectional Study

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Jiaxiu Ling, Hao Wang, Rui Liu, Juan Xiao, Sheng Qiu, Xiaotian Lei, Mengliu Yang, Yerui Lai, Hua Huang, Zerong Liang
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867002134026780673
author Jiaxiu Ling
Hao Wang
Rui Liu
Juan Xiao
Sheng Qiu
Xiaotian Lei
Mengliu Yang
Yerui Lai
Hua Huang
Zerong Liang
author_facet Jiaxiu Ling
Hao Wang
Rui Liu
Juan Xiao
Sheng Qiu
Xiaotian Lei
Mengliu Yang
Yerui Lai
Hua Huang
Zerong Liang
Jiaxiu Ling
Hao Wang
Rui Liu
Juan Xiao
Sheng Qiu
Xiaotian Lei
Mengliu Yang
Yerui Lai
Hua Huang
Zerong Liang
collection Wiley Open Access
contents Dickkopf1 as a Potential Biomarker in Polycystic Ovary Syndrome and Insulin Resistance: A Cross‐Sectional Study Jiaxiu Ling Hao Wang Rui Liu Juan Xiao Sheng Qiu Xiaotian Lei Mengliu Yang Yerui Lai Hua Huang Zerong Liang Journal of Diabetes ABSTRACT Background Dickkopf1 (DKK1) is a protein with established links to metabolic diseases. However, its association with polycystic ovary syndrome (PCOS) and insulin resistance (IR) remains ambiguous. Methods We conducted a cross‐sectional study involving 300 participants, including 100 healthy women, 100 women with PCOS, and 100 individuals with IR. Protein interactions with DKK1 were identified using the STRING database, followed by KEGG and GO analyses to explore enriched biological processes. Serum DKK1 and Adipoq levels were measured using ELISA kits. The hepatic DKK1 was detected by western blotting. Results Both IR and PCOS groups showed significantly higher serum DKK1 levels and lower Adipoq levels compared to controls. Serum DKK1 levels positively correlated with body mass index (BMI), waist‐hip ratio (WHR), body fat percentage (FAT%), systolic blood pressure (SBP), triglycerides (TG), fasting plasma glucose (FPG), fasting insulin (FIns), glycosylated hemoglobin (HbA1c), homeostasis model assessment of insulin resistance (HOMA‐IR). Adipoq levels negatively correlated with glucose disposal rate (M‐value). Multiple regression analysis showed that BMI and Adipoq were independent factors affecting DKK1. Multiple stepwise regressions indicated that DKK1 is a risk factor for IR and PCOS. In the euglycemic‐hyperinsulinemic clamp (EHC) test, serum DKK1 levels increased in the PCOS patients and decreased in the IR patients at 30 min and returned to baseline at 60 min. Conclusions Elevated DKK1 levels are strongly associated with PCOS and IR, suggesting a potential role in their development. This insight paves the way for further investigations into the role of DKK1 in PCOS and IR. 10.1111/1753-0407.70168 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1111/1753-0407.70168
format Artículo Open Access
id wiley_oa_10_1111_1753_0407_70168
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Dickkopf1 as a Potential Biomarker in Polycystic Ovary Syndrome and Insulin Resistance: A Cross‐Sectional Study
Jiaxiu Ling
Hao Wang
Rui Liu
Juan Xiao
Sheng Qiu
Xiaotian Lei
Mengliu Yang
Yerui Lai
Hua Huang
Zerong Liang
Journal of Diabetes
Dickkopf1 as a Potential Biomarker in Polycystic Ovary Syndrome and Insulin Resistance: A Cross‐Sectional Study Jiaxiu Ling Hao Wang Rui Liu Juan Xiao Sheng Qiu Xiaotian Lei Mengliu Yang Yerui Lai Hua Huang Zerong Liang Journal of Diabetes ABSTRACT Background Dickkopf1 (DKK1) is a protein with established links to metabolic diseases. However, its association with polycystic ovary syndrome (PCOS) and insulin resistance (IR) remains ambiguous. Methods We conducted a cross‐sectional study involving 300 participants, including 100 healthy women, 100 women with PCOS, and 100 individuals with IR. Protein interactions with DKK1 were identified using the STRING database, followed by KEGG and GO analyses to explore enriched biological processes. Serum DKK1 and Adipoq levels were measured using ELISA kits. The hepatic DKK1 was detected by western blotting. Results Both IR and PCOS groups showed significantly higher serum DKK1 levels and lower Adipoq levels compared to controls. Serum DKK1 levels positively correlated with body mass index (BMI), waist‐hip ratio (WHR), body fat percentage (FAT%), systolic blood pressure (SBP), triglycerides (TG), fasting plasma glucose (FPG), fasting insulin (FIns), glycosylated hemoglobin (HbA1c), homeostasis model assessment of insulin resistance (HOMA‐IR). Adipoq levels negatively correlated with glucose disposal rate (M‐value). Multiple regression analysis showed that BMI and Adipoq were independent factors affecting DKK1. Multiple stepwise regressions indicated that DKK1 is a risk factor for IR and PCOS. In the euglycemic‐hyperinsulinemic clamp (EHC) test, serum DKK1 levels increased in the PCOS patients and decreased in the IR patients at 30 min and returned to baseline at 60 min. Conclusions Elevated DKK1 levels are strongly associated with PCOS and IR, suggesting a potential role in their development. This insight paves the way for further investigations into the role of DKK1 in PCOS and IR. 10.1111/1753-0407.70168 http://creativecommons.org/licenses/by/4.0/
title Dickkopf1 as a Potential Biomarker in Polycystic Ovary Syndrome and Insulin Resistance: A Cross‐Sectional Study
topic Journal of Diabetes
url https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.70168